New Developments
- This forum has 3,260 topics, 1,777 replies, and was last updated 1 year, 8 months ago by .
-
- Topic
- Voices
- Last Post
-
- A transcriptomic signature for risk-stratification and recurrence prediction in
- 1
- 3 years, 4 months ago
- Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associa
- 1
- 3 years, 4 months ago
- Molecular Profiling and Targeted Therapy in Cholangiocarcinoma: An Observational
- 1
- 3 years, 4 months ago
- Identification of tumor antigens and immune subtypes of cholangiocarcinoma for m
- 1
- 3 years, 4 months ago
- Targeting FGFR in intrahepatic cholangiocarcinoma [iCCA]: Leading the way for pr
- 1
- 3 years, 4 months ago
- Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerat
- 1
- 3 years, 4 months ago
- Investigational PARP inhibitors for the treatment of biliary tract cancer: spotl
- 1
- 3 years, 4 months ago
- Promising Molecular Targets for the Targeted Therapy of Biliary Tract Cancers: A
- 1
- 3 years, 4 months ago
- Cholangiocarcinoma: shedding light on the most promising drugs in clinical devel
- 1
- 3 years, 4 months ago
- The forum ‘New Developments’ is closed to new topics and replies.